Havrix, an inactivated hepatitis A virus vaccine: purified sterile suspension for i.m injection. Havrix, adult dose contains 1440 ELISA units of viral antigens in 1ml vial; child dose contains 720 ELISA units of viral antigens in 0.5ml vial. Dosage & admin: Adults and adolescents from
16    years onwards- a single dose of 'Havrix 1440 adult' (1ml dose) is used for primary immunisation.
Children & adolescents from age between 1 to 15 years- a single dose of 'Havrix 720 Junior'
(0.5ml dose) is used for primary immunisation. A booster dose is recommeded at any time between 6 and 12 months after the primary immunisation, in order to ensure long term protection.
Havrix is administered by i.m injection. The site of injection is the deltoid region in adults and older children, and antero-lateral part of the thigh in young children. The vaccine shou¬ld not be administered in the gluteal region. The vaccine should not be administered subcutaneously or intradermally since administration by these routes may result in a less than optimal anti-HAV antibody response. Havrix should under no circumstances be administered intravenously.
1.0ml (adult) in prefilled syringe: 1189.90 MRP